These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tardive dyskinesia syndrome in neuroleptic therapy. General considerations and clinical observations on forty cases investigated. Chiriţă V, Boişteanu P, Pirozynski T. Rev Med Chir Soc Med Nat Iasi; 1987; 91(1):53-64. PubMed ID: 2889249 [No Abstract] [Full Text] [Related]
3. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction. Normann C, Brandt C, Berger M, Walden J. Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353 [Abstract] [Full Text] [Related]
4. Toxic irreversible encephalopathy induced by lithium carbonate and haloperidol. A report of 2 cases. Sandyk R, Hurwitz MD. S Afr Med J; 1983 Nov 19; 64(22):875-6. PubMed ID: 6415823 [Abstract] [Full Text] [Related]
5. [Incompatibility of lithium therapy with neuroleptics. a case report (author's transl)]. Pühringer W, Kocher R, Gastpar M. Nervenarzt; 1979 Feb 19; 50(2):124-7. PubMed ID: 34111 [No Abstract] [Full Text] [Related]
6. Electroencephalographic changes and other indices of neurotoxicity with haloperidol-lithium therapy. Saran A, Addy O, Foliart RH, Schubert DS, Halaris A. Neuropsychobiology; 1989 Feb 19; 20(3):152-7. PubMed ID: 2569693 [Abstract] [Full Text] [Related]
7. Safety of the combination of lithium and neuroleptic drugs. Goldney RD, Spence ND. Am J Psychiatry; 1986 Jul 19; 143(7):882-4. PubMed ID: 2872825 [Abstract] [Full Text] [Related]
8. Early onset of severe dyskinesia following lithium-haloperidol treatment. Mann SC, Greenstein RA, Eilers R. Am J Psychiatry; 1983 Oct 19; 140(10):1385-6. PubMed ID: 6624983 [No Abstract] [Full Text] [Related]
9. Tardive dyskinesia in patients receiving lithium maintenance therapy. Perényi A, Szücs R, Frecska E. Biol Psychiatry; 1984 Nov 19; 19(11):1573-8. PubMed ID: 6151403 [No Abstract] [Full Text] [Related]
10. Treatment of tardive dyskinesia and mania with RBC lithium determinations. Ereshefsky L, Rubin TN, Friedman S. Am J Psychiatry; 1979 Apr 19; 136(4B):570-3. PubMed ID: 34329 [Abstract] [Full Text] [Related]
11. [Prevention of tardive dyskinesia caused by neuroleptic therapy]. Perényi A. Orv Hetil; 1981 Jul 05; 122(27):1627-30. PubMed ID: 6117046 [No Abstract] [Full Text] [Related]
12. Tardive dyskinesia in bipolar affective disorder: relationship to lithium therapy. Dinan TG, Kohen D. Br J Psychiatry; 1989 Jul 05; 155():55-7. PubMed ID: 2575003 [Abstract] [Full Text] [Related]
13. Iron pigment in the brain of a man with tardive dyskinesia. Campbell WG, Raskind MA, Gordon T, Shaw CM. Am J Psychiatry; 1985 Mar 05; 142(3):364-5. PubMed ID: 3970282 [Abstract] [Full Text] [Related]
14. The question of lithium/neuroleptic toxicity. Jeffries J, Remington G, Wilkins J. Can J Psychiatry; 1984 Nov 05; 29(7):601-4. PubMed ID: 6150756 [Abstract] [Full Text] [Related]
15. [Persistent neurological syndrome after treatment with lithium salts. Toxicity of the lithium-neuroleptic combination?]. Habib M, Khalil R, le Pensec-Bertrand D, Ali-Cherif A, Bongrand MC, Crevat A. Rev Neurol (Paris); 1986 Nov 05; 142(1):61-4. PubMed ID: 2871617 [Abstract] [Full Text] [Related]
16. To the incompatibility of haloperidol with lithium salts. Marhold J, Zimanová J, Lachman M, Král J, Vojtĕchovský M. Act Nerv Super (Praha); 1974 Aug 05; 16(3):199-200. PubMed ID: 4420744 [No Abstract] [Full Text] [Related]
17. Lithium interferes with reserpine-induced dopamine depletion. Reches A, Hassan MN, Jackson V, Fahn S. Ann Neurol; 1983 Jun 05; 13(6):671-3. PubMed ID: 6410976 [Abstract] [Full Text] [Related]
18. Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: tardive dyskinesia? Faheem AD, Brightwell DR, Burton GC, Struss A. Am J Psychiatry; 1982 Apr 05; 139(4):517-8. PubMed ID: 6121492 [No Abstract] [Full Text] [Related]
19. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients. Ghadirian AM, Annable L, Bélanger MC, Chouinard G. J Clin Psychiatry; 1996 Jan 05; 57(1):22-8. PubMed ID: 8543543 [Abstract] [Full Text] [Related]
20. Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome. Chaudhry R, Radonjic D, Waters B. Am J Psychiatry; 1982 May 05; 139(5):674-6. PubMed ID: 6122382 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]